SQI Diagnostics Inc. is a life sciences company based in Toronto, Canada, specializing in the development and commercialization of proprietary technologies for multiplexing diagnostics. Founded in 1999, the company offers a variety of products and services designed for the detection and quantification of proteins, antibodies, and DNA. Their systems include sqidworks, which allows for efficient plate loading and reporting; sqidlite, a benchtop device for processing single plates; and sqid-X, which utilizes Ig_plex technology for enhanced multiplexing capabilities. SQI's products serve diverse applications, including immunogenicity and bioanalysis, in vitro diagnostics, clinical testing, biomarker research, and assay development. The company caters to markets in pharmaceutical and biotechnology drug development, as well as human and animal health diagnostic testing.
Kane Biotech Inc., a biotechnology company, researches, develops, and commercializes technologies and products that prevent and remove microbial biofilms in Canada and internationally. It develops pet oral care solutions under the StrixNB and bluestem trademarks; animal and human wound care solutions under the DispersinB trademark; medical device coatings under the Aledex trademark; and shampoos for dogs, cats, and horses under the Alosera trademark. The company was founded in 2001 and is based in Winnipeg, Canada.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.